Teva buys majority stake in Immuneering, a genomic analysis company

Comment icon 0 Comments
Teva Pharmaceutical Industries said Monday it agreed to buy 51 percent of a Immuneering, a privately-held company in Cambridge, Mass., which... Read more

CSL, Novartis complete $275 million flu vaccine deal

Comment icon 0 Comments
Drugmakers Novartis and Australia-based CSL Limited, whose U.S. headquarters is in King of Prussia, said Sunday night they have completed a... Read more

Penn's Emanuel on high-priced drugs, high-priced technology, including Penn's

Comment icon 0 Comments
Ezekiel Emanuel, chair of the department of medical ethics and health policy at the University of Pennsylvania, is not afraid of delivering... Read more

GSK expanding new drug search efforts in San Diego

Comment icon 0 Comments
Drugmaker GlaxoSmithKline is based in London and has big operations around Philadelphia, but it is expanding its search for new drugs to finding... Read more

Veeva president on cloud computing, biotech regions and Yale

Comment icon 0 Comments
Veeva Systems Inc. serves as an example of Silicon Valley meeting the Delaware Valley, with new technology and venture capital meeting the... Read more

Laid off by J&J, biologist succeeds with own biotech firm, FlowMetric

Comment icon 0 Comments
Renold Capocasale and his team at FlowMetric and FlowMetric Diagnostics will show off their new, patented mobile flow cytometry unit Tuesday... Read more

Bill Clinton to speak on health care Monday in Philly

Comment icon 0 Comments
Former President Bill Clinton will talk about the future of health care Monday in Philadelphia at an invitation-only gathering of about 200... Read more

Teva buying Mylan stock as part of takeover attempt

Comment icon 0 Comments
Teva Pharmaceutical Industries, Ltd., has been trying to buy fellow giant generic drugmaker Mylan, Inc., and the latest step to emerge was... Read more